What's Happening?
A study published in Nature Genetics has introduced a novel method for mapping the three-dimensional structure of the genome in rare human immune cells, specifically type 3 innate lymphoid cells (ILC3s).
This approach allows researchers to trace physical contacts between regulatory DNA regions and gene promoters, providing a more precise view of how inherited risk contributes to diseases like Crohn's disease. The study identified over 100 candidate genes potentially linked to inflammatory bowel disease, including CLN3, a gene associated with neurodegenerative disorders.
Why It's Important?
This research advances the understanding of genetic risk factors for autoimmune diseases by revealing how noncoding DNA can influence gene regulation. The ability to map genome interactions in rare immune cells offers new opportunities for identifying disease mechanisms and potential therapeutic targets. This method could improve the interpretation of genetic risk and lead to more effective treatments for autoimmune and inflammatory diseases, benefiting patients and healthcare providers.
